| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Friedman Aviad is a Director at ORAMED PHARMACEUTICALS INC.. Recent SEC Form 4 filings include 2 buys and 0 sells.
Estimated insider holdings value: $27K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 9, 2018 | ORMP Oramed Pharmaceuticals Inc. | Director | Buy | 2,500 | $4.95 | $12,370.00 | +12.6% |